Literature DB >> 16212632

BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis.

Sundaram Hariharan1, Eric P Cohen, Brahm Vasudev, Rimas Orentas, Raphael P Viscidi, Justin Kakela, Brian DuChateau.   

Abstract

We evaluated twenty renal transplant subjects at various stages of BKV nephritis (BKVN) for BKV-specific IgG and IgM antibodies using ELISA technique and BKV-DNA using PCR. They were divided as early onset (n = 7), stabilizing (n = 3), resolved (n = 8) and late onset (n = 2) BKVN. BKV-specific antibodies and BKV-DNA were simultaneously determined. The mean BKV-specific IgG level in early onset and stabilizing BKVN were 64 and 39 EIA units, and were significantly lower than 138 EIA units seen in resolved BKVN, P = 0.007, P = 0.008. The mean BKV-specific IgM levels in stabilizing BKVN was higher than resolved BKVN (130 vs 51 EIA units), P = 0.006. Mean plasma BKV loads for each group were 955,925, 5642 and 42 copies/mL of plasma, respectively. Prospective study in six BKVN cases revealed mean IgG, IgM levels and BKV-DNA at the time of diagnosis of BKVN as 39, 110 EIA units and 586,758 copies/mL of plasma, respectively. After a mean period of 5.2 months, IgG level increased to 120 EIA units (p = 0.0058) and had no detectable viral copies in circulation. Recovery from BKVN and elimination of BKV is associated with the development of BKV-specific IgG antibodies and this provides insight into the role of humoral immunity to BKV in the pathogenesis of BKVN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212632     DOI: 10.1111/j.1600-6143.2005.01080.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

Review 1.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

Review 2.  Management of polyomavirus-associated nephropathy in renal transplant recipients.

Authors:  Dirk R J Kuypers
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

3.  Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Authors:  Parmjeet S Randhawa; Gaurav Gupta; Abhay Vats; Ron Shapiro; Raphael P Viscidi
Journal:  Clin Vaccine Immunol       Date:  2006-09

4.  Inhibitory effect of gamma interferon on BK virus gene expression and replication.

Authors:  Johanna R Abend; Jonathan A Low; Michael J Imperiale
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.

Authors:  P Randhawa; D V Pastrana; G Zeng; Y Huang; R Shapiro; P Sood; C Puttarajappa; M Berger; S Hariharan; C B Buck
Journal:  Am J Transplant       Date:  2015-03-03       Impact factor: 8.086

6.  BK virus antibody titers and intensity of infections after renal transplantation.

Authors:  Daniel L Bohl; Daniel C Brennan; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Eugene O Major; Gregory A Storch
Journal:  J Clin Virol       Date:  2008-08-03       Impact factor: 3.168

7.  Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

Authors:  Parmjeet Randhawa; Raphael Viscidi; Joseph J Carter; Denise A Galloway; Tim D Culp; Cathy Huang; Bala Ramaswami; Neil D Christensen
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

8.  Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.

Authors:  Sohrab Bodaghi; Patrizia Comoli; Robert Bösch; Alberta Azzi; Rainer Gosert; David Leuenberger; Fabrizio Ginevri; Hans H Hirsch
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

9.  longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.

Authors:  P Randhawa; D Bohl; D Brennan; K Ruppert; B Ramaswami; G Storch; J March; R Shapiro; R Viscidi
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

10.  Risk factors for polyoma virus nephropathy.

Authors:  Olivier Prince; Spasenija Savic; Michael Dickenmann; Jürg Steiger; Lukas Bubendorf; Michael J Mihatsch
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.